drugset / Trial / NCT00374530

Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2

NCT00374530

Completed 12 enrolled Danish Headache Center
RandomizedCrossoverDouble-blind

Summary

Before, during and after intravenous administration of PGE2 we score/measure headache, rCBF, blood flow in the middle cerebral artery and diameter of superficial temporal artery and correlate that to known pathophysiology of headache to see if PGE2 is involved in headache pathophysiology.

Timeline

Start
2006-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified Intravenous

Indications